ELIGIX

PHARMACEUTICALS, NAMELY ANTIBODIES BOUND TO HIGH-DENSITY MICROPARTICLES FOR USE IN THE TREATMENT OF CANCER, INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, AND ORGAN TRANSPLANT PATIENTS